» Authors » Michaela Voss

Michaela Voss

Explore the profile of Michaela Voss including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 69
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stancil S, Brewe M, Tumberger J, Bartkoski M, Burns A, Yeh H, et al.
Contemp Clin Trials . 2025 Mar; 152:107874. PMID: 40043750
Eating disorders (ED) affect 5 % of youth, are associated with reward system alterations, and lead to substantial morbidity. Naltrexone, an opioid antagonist, is used to treat ED behaviors such...
2.
Norton S, Baranger D, Young E, Voss M, Hansen I, Bondy E, et al.
Compr Psychoneuroendocrinol . 2023 Aug; 16:100191. PMID: 37635863
Stress-induced dysregulation of diurnal cortisol is a cornerstone of stress-disease theories; however, observed associations between cortisol, stress, and health have been inconsistent. The reliability of diurnal cortisol features may contribute...
3.
Stancil S, Yeh H, Brucks M, Bruce A, Voss M, Abdel-Rahman S, et al.
Front Psychiatry . 2023 Jul; 14:1161032. PMID: 37492067
Background: Eating Disorders (ED) affect up to 5% of youth and are associated with reward system alterations and compulsive behaviors. Naltrexone, an opioid antagonist, is used to treat ED behaviors...
4.
Moreau A, Voss M, Hansen I, Paul S, Barch D, Rogers C, et al.
Biol Psychiatry Glob Open Sci . 2023 May; 3(2):243-254. PMID: 37124359
Background: Prenatal selective serotonin reuptake inhibitor (SSRI) exposure has been inconsistently linked to depression, and little is known about neural correlates. We examined whether prenatal SSRI exposure is associated with...
5.
Hartman-Munick S, Lin J, Milliren C, Braverman P, Brigham K, Fisher M, et al.
JAMA Pediatr . 2022 Nov; 176(12):1225-1232. PMID: 36342721
Importance: The COVID-19 pandemic has affected youth mental health. Increases in site-specific eating disorder (ED) care have been documented; however, multisite studies demonstrating national trends are lacking. Objective: To compare...
6.
Stancil S, Voss M, Nolte W, Tumberger J, Adelman W, Abdel-Rahman S
Clin Transl Sci . 2022 Oct; 15(11):2732-2743. PMID: 36200172
Naltrexone (NTX), an opioid antagonist metabolized by aldo-keto reductase 1C4 (AKR1C4), is prescribed for psychiatric conditions like eating disorders with variable response. Systemic exposure is highly variable in adults, yet...
7.
Wright A, Weston S, Norton S, Voss M, Bogdan R, Oltmanns T, et al.
Health Psychol . 2022 Mar; 41(2):121-133. PMID: 35238582
Objective: Personality influences many aspects of the health process. It is unclear to what extent self- and informant-reports of the Big Five offer incremental validity for the prediction of inflammatory...
8.
Bondy E, Norton S, Voss M, Marks R, Boudreaux M, Treadway M, et al.
Brain Behav Immun Health . 2021 Sep; 13:100226. PMID: 34589741
Inflammation has been reliably associated with depression. However, the directionality of this association is poorly understood, with evidence that elevated inflammation may promote and precede the development of depression, as...
9.
Moser C, Voss M, Jansen-Kraly K, Jacobson J
J Adolesc Health . 2017 Oct; 61(5):661-662. PMID: 29061233
No abstract available.
10.
Teufel R, Gantert C, Voss M, Eisenreich W, Haehnel W, Fuchs G
J Biol Chem . 2011 Feb; 286(13):11021-34. PMID: 21296885
The widespread, long sought-after bacterial aerobic phenylalanine/phenylacetate catabolic pathway has recently been elucidated. It proceeds via coenzyme A (CoA) thioesters and involves the epoxidation of the aromatic ring of phenylacetyl-CoA,...